Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Nov 14, 2013 · 10-Q · 45 days after period end · 0001144204-13-061876
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$1.08M | -$1.15M | $694.00K | $704.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 14, 2013 · 45 d after period end
